Safety and efficacy of rozanolixizumab in patients with generalised myasthenia gravis (MycarinG): a randomised, double-blind, placebo-controlled, adaptive phase 3 study by Grosskreutz, Julian, Mantegazza, Renato, Vu, Tuan, Gayfieva, Maryam, Berube, Maxime, Bril, Vera, Ng, Eduardo, Siddiqi, Zaeem, Tyblova, Michaela, Jakubikova, Michala, Witting, Nanna, Stemmerik, Mads, Andersen, Henning, Mathis, Stéphane, Tranchant, Christine, Messai, Sihame, Nadaj-Pakleza, Aleksandra, Stojkovic, Tanya, Querin, Giorgia, Weiss, Nicolas, Magy, Laurent, Hänsel, Eike, Teußer, Lars-Malte, Hagenacker, Tim, Blaes, Franz, Schwarz, Margret, Wiendl, Heinz, Klotz, Luisa, Lammerskitten, Anna, Mantegazza, Renato, Maggi, Lorenzo, Rinaldi, Elena, Tuccillo, Francesco, Umehara, Haruna, Higashi, Keiko, Nakamura, Noriko, Kubota, Tomoya, Yamamoto, Sana, Yokoyama, Kazumasa, Oji, Yutaka, Uzawa, Akiyuki, Sanko, Miki, Nakayama, Mayumi, Masuda, Masayuki, Okubo, Yoshihiko, Minohara, Akiko, Haraguchi, Nana, Naito, Makiko, Fukushige, Yuri, Yoshimura, Shunsuke, Hirayama, Takuro, Okamoto, Naoko, Sekiguchi, Kenji, Chihara, Norio, Suzuki, Shigeaki, Komatsu, Yuka, Tsukita, Kenichi, Watanabe, Genya, Sato, Kazuki, Kawasaki, Emiko, Ono, Hirohiko, Sugimoto, Takamichi, Kitowska, Monika, Zaslavskiy, Leonid, Skornyakova, Evgeniya, Novikova, Ekaterina, Sidorova, Olga, Malkova, Nadezhda, Korobko, Denis, Stojanov, Aleksandar, Peric, Stojan, Lavrnic, Dragana, Casasnovas, Carlos, Querol Gutiérrez, Luis, Canovas Segura, Anna, Juntas Morales, Raúl, Llufriú Durán, Sara, Gutiérrez Gutiérrez, Gerardo, Yeh, Jiann-Horng, Lee, Mei Fen, Akhter, Salma, Lam, Lucy, Holzberg, Shara, Ashworth, Lisa, Bender, Kathryn, Gandhi Mehta, Rachana, Miller, Gina, Smith, Rose, Rosow, Laura, Kang, Min, Denny, Carol, Hanson, Bart, Klein, Sara, Martinez-Thompson, Jennifer, Padgett, Denny, Sorenson, Eric, Baras, Gelasio, Mahuwala, Zabeen, Ryan, Stephen, Sharma, Khema

Get full text

Rozanolixizumab responder and minimal symptom expression rates in generalized myasthenia gravis: Pooled phase 3 and extension studies by Bril, Vera, Vissing, John, Drużdż, Artur, Grosskreutz, Julian, Habib, Ali A., Mantegazza, Renato, Sacconi, Sabrina, Utsugisawa, Kimiaki, Vu, Tuan, Boehnlein, Marion, Greve, Bernhard, Woltering, Franz, Gayfieva, Maryam

Get full text

2634 Cyclical rozanolixizumab treatment in generalised myasthenia gravis (gMG): pooled analysis of MycarinG (Phase 3 study) and two open-label extension studies by Welton, Jeremy M, Bril, Vera, Dru d, Artur, Grosskreutz, Julian, Habib, Ali A, Mantegazza, Renato, Utsugisawa, Kimiaki, Vissing, John, Vu, Tuan, Boehnlein, Marion, Gayfieva, Maryam, Greve, Bernhard, Woltering, Franz, Kaminski, Henry J

Request full text